CVS HEALTH Corp (CVS) Financial Statements
Industry: Drug Stores and Proprietary Stores (Retail)
In fiscal 2025, CVS HEALTH reported revenue of $402.07B, up 7.8% from $372.81B the year before. Net income was $1.77B (a 0.4% net margin), or $1.39 per diluted share. Gross margin was 45.0% and operating margin was 1.2%. Operating activities generated $10.64B of cash, leaving $7.81B of free cash flow. At fiscal year end, CVS HEALTH held $253.54B in total assets against $178.16B in total liabilities, including $8.45B of cash and equivalents.
Open the full interactive CVS HEALTH financials → Quarterly statements, key ratios, valuation history and price charts.
CVS HEALTH Key Stats
| Share Price | $87.55 |
|---|---|
| Market Cap | $112.68B |
| P/E Ratio | 63.0 |
| Dividend Yield | 3.03% |
| Revenue YoY Growth | +7.8% |
| 52-Week Range | $69.04 – $109.92 |
| Shares Outstanding | 1.28 billion (basic, 2026 Q2) |
CVS HEALTH Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $268.71B | $292.11B | $322.47B | $357.78B | $372.81B | $402.07B |
| Cost of Goods Sold | $163.98B | $175.80B | $196.89B | $217.10B | $206.29B | $221.17B |
| Gross Profit | $104.72B | $116.31B | $125.58B | $140.68B | $166.52B | $180.90B |
| Operating Income | $13.91B | $13.19B | $7.75B | $13.74B | $8.52B | $4.66B |
| Pre-Tax Income | $9.77B | $10.42B | $5.63B | $11.17B | $6.15B | $2.14B |
| Income Tax | $2.57B | $2.52B | $1.46B | $2.81B | $1.56B | $408.0M |
| Net Income | $7.18B | $7.91B | $4.15B | $8.34B | $4.61B | $1.77B |
| Diluted EPS | $5.46 | $5.95 | $3.14 | $6.47 | $3.66 | $1.39 |
CVS HEALTH Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $102.87B | $105.69B | $100.43B | $106.10B |
| Net Income | -$3.98B | $2.94B | $2.94B | $2.98B |
| Diluted EPS | -$3.13 | $2.32 | $2.30 | $2.31 |
CVS HEALTH Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $7.85B | $9.41B | $12.95B | $8.20B | $8.59B | $8.45B |
| Current Assets | $56.37B | $60.01B | $65.68B | $67.86B | $68.64B | $74.71B |
| Total Assets | $230.72B | $233.00B | $228.28B | $249.73B | $253.22B | $253.54B |
| Current Liabilities | $62.02B | $67.81B | $69.74B | $79.19B | $84.61B | $88.69B |
| Total Long-Term Debt | $64.65B | $56.18B | $52.25B | $61.41B | $64.15B | $64.57B |
| Total Liabilities | $161.01B | $157.62B | $156.96B | $173.09B | $177.49B | $178.16B |
| Shareholders' Equity | $69.39B | $75.08B | $71.02B | $76.46B | $75.56B | $75.21B |
CVS HEALTH Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $15.87B | $18.27B | $16.18B | $13.43B | $9.11B | $10.64B |
| Cash From Investing | -$5.53B | -$5.26B | -$5.05B | -$20.89B | -$7.61B | -$5.87B |
| Cash From Financing | -$8.15B | -$11.36B | -$10.52B | $2.68B | -$1.14B | -$4.94B |
| Free Cash Flow | $13.43B | $15.74B | $13.45B | $10.39B | $6.33B | $7.81B |
| Dividends Paid | $2.62B | $2.62B | $2.91B | $3.13B | $3.37B | $3.40B |
Figures from CVS HEALTH's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full CVS HEALTH financials page for every line item.
CVS HEALTH Company Profile
| Ticker | CVS |
|---|---|
| Exchange | NYSE |
| Industry | Drug Stores and Proprietary Stores (Retail) |
| Headquarters | Woonsocket, Rhode Island |
| Incorporated in | Delaware |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000064803 |
Frequently Asked Questions
What was CVS HEALTH's revenue in fiscal 2025?
CVS HEALTH (CVS) reported revenue of $402.07B for fiscal 2025.
What is CVS HEALTH's annual revenue history?
CVS HEALTH's annual revenue by fiscal year: 2020: $268.71B; 2021: $292.11B; 2022: $322.47B; 2023: $357.78B; 2024: $372.81B; 2025: $402.07B.
What was CVS HEALTH's net income in fiscal 2025?
CVS HEALTH reported net income of $1.77B for fiscal 2025.
What was CVS HEALTH's earnings per share (EPS) in fiscal 2025?
CVS HEALTH's diluted EPS was $1.39 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did CVS HEALTH generate in fiscal 2025?
CVS HEALTH generated $7.81B of free cash flow in fiscal 2025.
What was CVS HEALTH's revenue last quarter?
In its most recent reported quarter (2026 Q2), CVS HEALTH reported revenue of $106.10B.
How much debt does CVS HEALTH have?
CVS HEALTH reported $64.57B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of CVS HEALTH are outstanding?
CVS HEALTH reported a weighted average of 1.28 billion basic shares outstanding in 2026 Q2.
What is CVS HEALTH's market cap?
Based on its latest closing price, CVS HEALTH (CVS) has a market capitalization of about $112.68B.
When does CVS HEALTH's fiscal year end?
CVS HEALTH's fiscal year end, as registered with the SEC, is December 31.
Where is CVS HEALTH headquartered?
CVS HEALTH lists its business address in Woonsocket, Rhode Island in its SEC filings.